Fourier Health vs MedScrub
Both summarise clinical records and they solve the trust problem in opposite directions. Fourier puts humans in the loop, with a clinician network reviewing output and every statement attributed to its source, and it ingests the mess directly including faxes and handwritten notes. MedScrub removes the exposure instead, stripping the patient out before anything reaches a model, letting the customer choose which model runs, and re identifying on the way back. Each answer has a cost. De identification is imperfect and residual re identification risk in free clinical text cannot be contracted away. A review network means people outside your organisation are reading your patients' records, and no contracting terms for that chain were located. Decide which residual risk your governance committee would rather own.
- Summaries are shaped to the use case rather than produced in one general format, with every statement attributed to its source and a clinician network reviewing output.
- It ingests the messy reality directly, including faxes, handwritten notes and records retrieved through exchanges, rather than assuming structured input.
- For a buyer who wants finished summaries rather than infrastructure, it is the shorter path to something clinicians will actually read.
- The patient is stripped out before anything reaches a model and re identified on the way back, so the model provider never sees identified data.
- The customer chooses which model runs, which answers the provenance question completely rather than asking a buyer to trust the vendor's choice.
- For an organisation whose legal team has blocked sending records to an external model, this removes the blocker rather than papering over it.
Side by Side
| Axis | F Fourier Health |
M MedScrub |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.
The two treat the privacy problem in opposite ways and both approaches have limits worth naming: de identification is imperfect and residual re identification risk in free clinical text cannot be contracted away, while a human review network means real people outside your organisation are reading patient records, with no contracting terms for that chain located.
Neither publishes an accuracy or completeness figure, an independent evaluation or a named deployment with a measured result, so a pilot is the only evidence available. Neither publishes a security attestation or pricing.